Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Bearish
3
Neutral
7
Bullish
4
Bearish
13
Neutral
7
Bullish
26
Bearish
10
Neutral
0
Bullish
22
Discovery themes featuring this stock
Shaily Engineering Plastics Limited is India’s largest exporter of precision injection‑moulded plastic components, offering end‑to‑end manufacturing, assembly and metrology services across Consumer, Industrial and Healthcare segments from seven plants in Gujarat and overseas subsidiaries, supported by 200+ injection moulding machines and over 2,000 employees.
Healthcare has become the company’s primary growth engine: Healthcare revenue grew 158% for 9M FY26 and contributed 42% of Q3 revenue, propelled by pen injector programs, two new GLP‑1 customers, two global pharma contracts and ongoing line additions that aim to scale device manufacturing for GLP‑1 and other advanced therapies.
Financially, Shaily reported consolidated revenue growth of +32% for 9M FY26 with gross margin expansion of ~1,090 basis points YoY and EBITDA margin rising to 29.0%; RoCE improved to 38.4% while Total Debt/Equity fell to 0.3x, reflecting improving operating leverage and stronger cash generation.
Execution and timing are material: India high‑speed lines are in qualification with staggered commercialisation through mid‑2026, while a large Abu Dhabi facility (AED130–150m) targets Q4 FY28 start; management reports India expansions are mostly contract‑backed but Abu Dhabi is currently ~50–60% secured, so scale benefits depend on timely execution and additional book‑ings.
The company is also diversifying into higher‑precision consumer electronics and semiconductor casing opportunities, supported by a UK medical device R&D center and investments in automation, metrology and toolroom upgrades, indicating a strategic pivot to higher value, defendable engineering plastics applications.
Industrial Products
Plastic Products - Industrial
12,951 Cr
Low Risk
76.2
37.7
1.2
18.1
3,222.00
1,534.25
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
6650.00 | 15,480 Cr | 45.77 | 5.83 | 0.18 | 12.73 | 17.01 | 11.23 | ||
2810.85 | 12,951 Cr | 76.22 | 18.07 | 0.11 | 23.71 | 26.67 | 14.82 | ||
183.55 | 11,411 Cr | 19.05 | 1.84 | 1.49 | 9.64 | 12.34 | 7.89 | ||
178.10 | 8,804 Cr | 18.78 | 2.15 | 0.84 | 11.46 | 14.89 | 8.45 | ||
5064.80 | 6,851 Cr | 36.98 | 4.90 | 0.00 | 13.24 | 17.92 | 10.56 | ||
291.50 | 3,232 Cr | 44.17 | 1.97 | 0.34 | 4.45 | 6.11 | 3.02 | ||
35.78 | 2,604 Cr | -105.82 | 0.44 | 0.00 | -0.49 | 5.25 | -0.33 | ||
| Median: 7 Co. | — | 291.50 | 8,804 Cr | 36.98 | 2.15 | 0.18 | 11.46 | 14.89 | 8.45 |
Shaily Engineering Plastics Ltd (SHAILY) is currently trading at 2,838.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Shaily Engineering Plastics Limited is India’s largest exporter of precision injection‑moulded plastic components, offering end‑to‑end manufacturing, assembly and metrology services across Consumer, Industrial and Healthcare segments from seven plants in Gujarat and overseas subsidiaries, supported by 200+ injection moulding machines and over 2,000 employees. Healthcare has become the company’s primary growth engine: Healthcare revenue grew 158% for 9M FY26 and contributed 42% of Q3 revenue, propelled by pen injector programs, two new GLP‑1 customers, two global pharma contracts and ongoing line additions that aim to scale device manufacturing for GLP‑1 and other advanced therapies. Financially, Shaily reported consolidated revenue growth of +32% for 9M FY26 with gross margin expansion of ~1,090 basis points YoY and EBITDA margin rising to 29.0%; RoCE improved to 38.4% while Total Debt/Equity fell to 0.3x, reflecting improving operating leverage and stronger cash generation. Execution and timing are material: India high‑speed lines are in qualification with staggered commercialisation through mid‑2026, while a large Abu Dhabi facility (AED130–150m) targets Q4 FY28 start; management reports India expansions are mostly contract‑backed but Abu Dhabi is currently ~50–60% secured, so scale benefits depend on timely execution and additional book‑ings. The company is also diversifying into higher‑precision consumer electronics and semiconductor casing opportunities, supported by a UK medical device R&D center and investments in automation, metrology and toolroom upgrades, indicating a strategic pivot to higher value, defendable engineering plastics applications.
Over the past 52 weeks, Shaily Engineering Plastics Ltd has traded between a low of ₹1,534.25 and a high of ₹3,222.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Shaily Engineering Plastics Ltd has a market capitalization of approximately 12,951.34. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Shaily Engineering Plastics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 76.22 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 12,951.34 Cr, Shaily Engineering Plastics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Shaily Engineering Plastics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Shaily Engineering Plastics Ltd is 76.22. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The company said its Q4 FY26 results were declared on May 19, 2026, for the quarter ended March 31, 2026.
